SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001599901-24-000121
Filing Date
2024-08-05
Accepted
2024-08-05 09:06:57
Documents
4
Period of Report
2024-08-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1722863209.html 3  
1 FORM 3 wk-form3_1722863209.xml 3 1713
2 EX-24 poajmoriarty.htm EX-24 5945
3 GRAPHIC poajmoriarty001.jpg GRAPHIC 247010
4 GRAPHIC poajmoriarty002.jpg GRAPHIC 115645
  Complete submission text file 0001599901-24-000121.txt   509074
Mailing Address ALEXION PHARMACEUTICALS 352 KNOTTER DRIVE CHESHIRE CT 06410
Business Address
Moriarty John B (Reporting) CIK: 0001564621 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39321 | Film No.: 241173277

Mailing Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121 858-401-7900
Avidity Biosciences, Inc. (Issuer) CIK: 0001599901 (see all company filings)

IRS No.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)